Ann: Combined FOXFIRE Study Data Presented at ASCO Annual Meeting, page-52

First 52 Last

Share
Profile

Follow
Andrewjackson

456 Posts.

55

06/06/17

17:03

Post #: 25130133
Share

Originally posted by slc4me ↑

Well what can I say "liar liar pants on fire". Thought I would keep it simple for you.

You said today... "Believe what you want, but last week when i said SRX will go down to $10-$11 you guys laughed, but i guess i was right that this was the correct entry point.."

Now today is the 6th of June. Now even if I am generous to you and give you the whole of the week (ie 29th to the 2nd of June) the price did not fall below $11.00. So no order filled there. No entry point for you and yes you were correct - we were laughing at you.

Now all of a sudden it has spread out to two weeks (the technical term for this is called “liars creep”). Well guess what? The price between the 22nd of May and the 26th did not fall below $11.00. So no order filled there as well. Well that’s embarrassing. So caught out in a lie again. But wait there is more (there always is with serial liars).

Your post 24786756 on the 19th of May – the last day the share price was below $11.00 (a low of $10.95 but closed at $11.50 – so you had to be mighty quick to buy sub $11.00.) You said – and I will put it in capitals for you “….SRX IS DEFINITELY BELOW THE $10 MARK..” Your position was Sentiment: None, Disclosure Not Held.

Well well well there we have it again. So not only did you not buy at your own entry point you were calling the entry sub $10 – which as you were aware SRX did not get to – so you adjusted your lie to $10 to $11. Are you not just a tad ashamed? Now do us all a favour and just stop embarrassing yourself and maybe come back and post when your testicles have dropped.

Expand

he might be giggling in his bed with a pacifier in his mouth right now successfully trolling us but actually he is kinda funny so keep coming at us bro we pretend you aint trollin. talk soon nikhilc babe

Last edited by Andrewjackson: 06/06/17

SRX Price at posting: $11.54 Sentiment: None Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 17 more messages in this thread...

First 52 Last

Add SRX (ASX) to my watchlist

Ann: Combined FOXFIRE Study Data Presented at ASCO Annual Meeting, page-52

Top Stories

Buxton projects new graphite province discovery at WA Narryer play

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI reaches close of funding facility for salt-first part of Mardie project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News